{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:59:15Z","timestamp":1791917955376,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.healun.2017.02.008","type":"journal-article","created":{"date-parts":[[2017,2,11]],"date-time":"2017-02-11T02:16:30Z","timestamp":1486779390000},"page":"616-624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Circulating microRNA-150-5p as a novel biomarker for advanced heart failure: A genome-wide prospective study"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8535-3264","authenticated-orcid":false,"given":"Domenico","family":"Scrutinio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Conserva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Passantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Iacoviello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Lagioia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2017.02.008_bib1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Global Burden of Disease Study","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2017.02.008_bib2","first-page":"e38","article-title":"Heart Disease and Stroke Statistics\u20142016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2017.02.008_bib3","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/eurheartj\/ehi603","article-title":"Compliance in heart failure patients: the importance of knowledge and beliefs","volume":"10","author":"van der Wal","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2017.02.008_bib4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.hfc.2016.03.001","article-title":"Advanced heart failure: prevalence, natural history, and prognosis","volume":"12","author":"Chaudhry","year":"2016","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.healun.2017.02.008_bib5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cardfail.2016.03.003","article-title":"Defining advanced heart failure: a systematic review of criteria used in clinical trials","volume":"22","author":"Bjork","year":"2016","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2017.02.008_bib6","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2017.02.008_bib7","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ejheart.2007.04.003","article-title":"Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology","volume":"9","author":"Metra","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.healun.2017.02.008_bib8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.healun.2009.02.015","article-title":"INTERMACS profiles of advanced heart failure: the current picture","volume":"28","author":"Stevenson","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.02.008_bib9","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.healun.2015.10.037","article-title":"INTERMACS profiles and modifiers: Heterogeneity of patient classification and the impact of modifiers on predicting patient outcome","volume":"35","author":"Cowger","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.02.008_bib10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s11897-014-0195-7","article-title":"Decision-making under uncertainty in advanced heart failure","volume":"11","author":"Meyer","year":"2014","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.healun.2017.02.008_bib11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/heartjnl-2013-305402","article-title":"MicroRNAs in cardiovascular disease: an introduction for clinicians","volume":"101","author":"Romaine","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.healun.2017.02.008_bib12","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/ijms17040502","article-title":"MicroRNA and heart failure","volume":"17","author":"Wong","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.healun.2017.02.008_bib13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1126\/science.1139089","article-title":"Control of stress-dependent cardiac growth and gene expression by a microRNA","volume":"316","author":"van Rooij","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.healun.2017.02.008_bib14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nm1582","article-title":"MicroRNA-133 controls cardiac hypertrophy","volume":"13","author":"Car\u00e8","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.healun.2017.02.008_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10557-011-6289-5","article-title":"Role of microRNAs in cardiac remodeling and heart failure","volume":"25","author":"Topkara","year":"2011","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.healun.2017.02.008_bib16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijcard.2016.06.185","article-title":"Advanced research on the microRNA mechanism in heart failure","volume":"220","author":"Deng","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.healun.2017.02.008_bib17","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/jcmm.12096","article-title":"Identification of micro-RNA networks in end-stage heart failure because of dilated cardiomyopathy","volume":"17","author":"Zhu","year":"2013","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.healun.2017.02.008_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrcardio.2009.56","article-title":"MicroRNAs and cardiac pathology","volume":"6","author":"Latronico","year":"2009","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.healun.2017.02.008_bib19","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/CIRCRESAHA.108.183426","article-title":"Toward microRNA-based therapeutics for heart disease: the sense in antisense","volume":"103","author":"van Rooij","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.healun.2017.02.008_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1021\/pr800545q","article-title":"Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group","volume":"8","author":"Tuck","year":"2009","journal-title":"J Proteome Res"},{"key":"10.1016\/j.healun.2017.02.008_bib21","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","article-title":"The Seattle Heart Failure Model: prediction of survival in heart failure","volume":"113","author":"Levy","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2017.02.008_bib22","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1161\/CIRCULATIONAHA.109.870006","article-title":"The heart failure spectrum: time for a phenotype-oriented approach","volume":"119","author":"De Keulenaer","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2017.02.008_bib23","doi-asserted-by":"crossref","first-page":"e003032","DOI":"10.1161\/CIRCHEARTFAILURE.116.003032","article-title":"INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) profiling identifies ambulatory patients at high risk on medical therapy after hospitalizations for heart failure","volume":"9","author":"Stewart","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2017.02.008_bib24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1161\/ATVBAHA.112.300141","article-title":"MicroRNAs within the continuum of postgenomics biomarker discovery","volume":"33","author":"Mayr","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.healun.2017.02.008_bib25","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.amjcard.2012.12.048","article-title":"Association between bilirubin and mode of death in severe systolic heart failure","volume":"111","author":"Wu","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.healun.2017.02.008_bib26","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJM199704173361603","article-title":"Apoptosis in the failing human heart","volume":"336","author":"Olivetti","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2017.02.008_bib27","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM199610173351603","article-title":"Apoptosis in myocytes in end-stage heart failure","volume":"335","author":"Narula","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2017.02.008_bib28","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1172\/JCI17664","article-title":"A mechanistic role for cardiac myocyte apoptosis in heart failure","volume":"111","author":"Wencker","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.healun.2017.02.008_bib29","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jacc.2004.05.090","article-title":"Ventricular assist device therapy normalizes inducible nitric oxide synthase expression and reduces cardiomyocyte apoptosis in the failing human heart","volume":"45","author":"Patten","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2017.02.008_bib30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1172\/JCI24569","article-title":"Death begets failure in the heart","volume":"115","author":"Foo","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.healun.2017.02.008_bib31","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1172\/JCI17459","article-title":"Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy","volume":"111","author":"Yamamoto","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.healun.2017.02.008_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00395-016-0549-2","article-title":"Myocardial apoptosis in heart disease: does the emperor have clothes?","volume":"111","author":"Jose","year":"2016","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.healun.2017.02.008_bib33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.tcm.2015.05.008","article-title":"Targeting microRNAs in heart failure","volume":"26","author":"Duygu","year":"2016","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.healun.2017.02.008_bib34","doi-asserted-by":"crossref","first-page":"10782","DOI":"10.1158\/0008-5472.CAN-07-1484","article-title":"Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway","volume":"67","author":"Ovcharenko","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.healun.2017.02.008_bib35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1517\/14728222.2013.745513","article-title":"Caspase-3 as a therapeutic target for heart failure","volume":"17","author":"Yang","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.healun.2017.02.008_bib36","doi-asserted-by":"crossref","first-page":"28274","DOI":"10.1074\/jbc.M802663200","article-title":"MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3\u05f3-untranslated region of the gene that decrease steady-state levels of the transcript","volume":"283","author":"Zhou","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.healun.2017.02.008_bib37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/cvr\/cvv121","article-title":"MicroRNA-150 protects the mouse heart from ischaemic injury by regulating cell death","volume":"106","author":"Tang","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.healun.2017.02.008_bib38","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/CIRCRESAHA.114.302766","article-title":"\u03b2-arrestin1-biased \u03b21-adrenergic receptor signaling regulates microRNA processing","volume":"114","author":"Kim","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.healun.2017.02.008_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3892\/ol.2015.3170","article-title":"Role of microRNA-150 in solid tumors","volume":"10","author":"Wang","year":"2015","journal-title":"Oncol Lett"},{"key":"10.1016\/j.healun.2017.02.008_bib40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1756-9966-30-87","article-title":"Apoptosis in cancer: from pathogenesis to treatment","volume":"30","author":"Wong","year":"2011","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.healun.2017.02.008_bib41","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1161\/01.RES.0000148632.35500.d9","article-title":"The mitochondrial death pathway and cardiac myocyte apoptosis","volume":"95","author":"Crow","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.healun.2017.02.008_bib42","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1253\/circj.CJ-11-0025","article-title":"Apoptosis in heart failure. The role of the \u03b2-adrenergic receptor-mediated signaling pathway and p53-mediated signaling pathway in the apoptosis of cardiomyocytes","volume":"75","author":"Fujita","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.healun.2017.02.008_bib43","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S1053-2498(98)00039-4","article-title":"Increased p53 protein expression in human failing myocardium","volume":"18","author":"Song","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.02.008_bib44","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/cvr\/cvn083","article-title":"Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy","volume":"79","author":"Birks","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.healun.2017.02.008_bib45","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1161\/CIRCRESAHA.109.214346","article-title":"Promotion of CHIP-mediated p53 degradation protects the heart from ischemic injury","volume":"106","author":"Naito","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.healun.2017.02.008_bib46","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jmcb\/mju018","article-title":"New insights into p53 functions through its target microRNAs","volume":"6","author":"Liao","year":"2014","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.healun.2017.02.008_bib47","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/15476286.2015.1014288","article-title":"Transcriptional regulation of microRNA-100, -146a, and -150 genes by p53 and NF\u03baB p65\/RelA in mouse striatal STHdh(Q7)\/Hdh(Q7) cells and human cervical carcinoma HeLa cells","volume":"12","author":"Ghose","year":"2015","journal-title":"RNA Biol"},{"key":"10.1016\/j.healun.2017.02.008_bib48","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1159\/000445568","article-title":"MicroRNA-150 Inhibits the activation of cardiac fibroblasts by regulating c-Myb","volume":"38","author":"Deng","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.healun.2017.02.008_bib49","doi-asserted-by":"crossref","first-page":"729","DOI":"10.15252\/emmm.201505925","article-title":"Endoplasmic reticulum stress enhances fibrosis through IRE1\u03b1-mediated degradation of miR-150 and XBP-1 splicing","volume":"8","author":"Heindryckx","year":"2016","journal-title":"EMBO Mol Med"},{"issue":"12","key":"10.1016\/j.healun.2017.02.008_bib50","doi-asserted-by":"crossref","first-page":"e115577","DOI":"10.1371\/journal.pone.0115577","article-title":"miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.healun.2017.02.008_bib51","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCRESAHA.112.266882","article-title":"Membrane-associated matrix proteolysis and heart failure","volume":"112","author":"Spinale","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.healun.2017.02.008_bib52","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/CIRCGENETICS.113.000077","article-title":"MicroRNA-150: a novel marker of left ventricular remodeling after acute myocardial infarction","volume":"6","author":"Devaux","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.healun.2017.02.008_bib53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cardiores.2005.04.012","article-title":"Myocyte apoptosis in heart failure","volume":"67","author":"van Empel","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.healun.2017.02.008_bib54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrcardio.2012.158","article-title":"Myofibroblast-mediated mechanisms of pathological remodelling of the heart","volume":"10","author":"Weber","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.healun.2017.02.008_bib55","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.ehj.2004.06.036","article-title":"The pro-apoptotic serum activity is an independent mortality predictor of patients with heart failure","volume":"25","author":"Rossig","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2017.02.008_bib56","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/eurheartj\/ehp004","article-title":"Prognostic value of apoptosis markers in advanced heart failure patients","volume":"30","author":"Niessner","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2017.02.008_bib57","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jchf.2015.04.011","article-title":"\u201cTargeting the Heart\u201d in heart failure: myocardial recovery in heart failure with reduced ejection fraction","volume":"3","author":"Wilcox","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.healun.2017.02.008_bib58","first-page":"250","article-title":"Concurrent upregulation of endogenous proapoptotic and antiapoptotic factors in failing human hearts","volume":"6","author":"Haider","year":"2009","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.healun.2017.02.008_bib59","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1373\/clinchem.2015.239459","article-title":"Data normalization strategies for microRNA quantification","volume":"61","author":"Schwarzenbach","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.healun.2017.02.008_bib60","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/CIRCRESAHA.113.300226","article-title":"Non-coding RNAs in cardiac remodeling and heart failure","volume":"113","author":"Kumarswamy","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.healun.2017.02.008_bib61","doi-asserted-by":"crossref","first-page":"e89565","DOI":"10.1371\/journal.pone.0089565","article-title":"A critical evaluation of microRNA biomarkers in non-neoplastic disease","volume":"9","author":"Haider","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.healun.2017.02.008_bib62","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCRESAHA.113.300975","article-title":"Regulation of cardiac microRNAs by cardiac microRNAs","volume":"113","author":"Matkovich","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.healun.2017.02.008_bib63","unstructured":"miRIAD: intragenic microRNA database. https:\/\/www.bioinfo.mochsl.org.br\/miriad\/miRNA\/hsa-mir-150\/. Accessed August 20, 2016."},{"key":"10.1016\/j.healun.2017.02.008_bib64","doi-asserted-by":"crossref","first-page":"18255","DOI":"10.1073\/pnas.0608791103","article-title":"A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure","volume":"103","author":"van Rooij","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.healun.2017.02.008_bib65","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/CIRCRESAHA.108.183087","article-title":"The emerging role of microRNAs in cardiac remodeling and heart failure","volume":"103","author":"Divakaran","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.healun.2017.02.008_bib66","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.healun.2013.10.014","article-title":"MicroRNA-150 inhibits expression of adiponectin receptor 2 and is a potential therapeutic target in patients with chronic heart failure","volume":"33","author":"Kreth","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2017.02.008_bib67","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/CIRCULATIONAHA.107.687947","article-title":"MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure","volume":"116","author":"Thum","year":"2007","journal-title":"Circulation"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249817313724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249817313724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:33:00Z","timestamp":1760949180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249817313724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1053249817313724"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2017.02.008","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating microRNA-150-5p as a novel biomarker for advanced heart failure: A genome-wide prospective study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2017.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for the Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}